CymitQuimica logo
Apoptose

Apoptose

Les inhibiteurs de l'apoptose sont des composés qui empêchent ou retardent le processus de mort cellulaire programmée, connu sous le nom d'apoptose. Ces inhibiteurs sont essentiels pour étudier les mécanismes de survie cellulaire et sont utilisés pour enquêter sur les maladies où l'apoptose est dysrégulée, telles que le cancer, les troubles neurodégénératifs et les maladies auto-immunes. En modulant l'apoptose, ces inhibiteurs peuvent aider au développement de thérapies visant à contrôler la mort cellulaire. Chez CymitQuimica, nous offrons une sélection complète d'inhibiteurs de l'apoptose de haute qualité pour soutenir vos recherches en biologie cellulaire, oncologie et domaines connexes.

Sous-catégories appartenant à la catégorie "Apoptose"

Affichez 6 plus de sous-catégories

6222 produits trouvés pour "Apoptose"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • H3B-8800

    CAS :
    H3B-8800 is an SF3B1 modulator that can be used to study transfusion-dependent anemia.
    Formule :C31H45N3O6
    Degré de pureté :98.31%
    Couleur et forme :Soild
    Masse moléculaire :555.71

    Ref: TM-T77595

    1mg
    268,00€
    5mg
    707,00€
    50mg
    2.602,00€
  • RSM3 TFA


    RSM3 TFA is a stapled peptide and an inhibitor of METTL3-METTL14, exhibiting a dissociation constant (Kd) of 3.10 μM. It inhibits tumor growth and induces cell apoptosis. RSM3 TFA is utilized in cancer research.
    Couleur et forme :Odour Solid

    Ref: TM-TP2889

    10mg
    À demander
    50mg
    À demander
  • ZYH-23


    ZYH-23 is a potent inhibitor of necroptosis. It targets HSP90 to inhibit the phosphorylation of RIPK1, RIPK3, and MLKL, effectively blocking programmed cell necrosis.
    Formule :C41H50N4O3
    Couleur et forme :Solid
    Masse moléculaire :646.38829

    Ref: TM-T207337

    10mg
    À demander
    50mg
    À demander
  • ZS3-046


    ZS3-046 is a TAF1 PROTAC degrader that facilitates the ubiquitination and subsequent degradation of TAF1. It can activate p53 and induce apoptosis in acute myeloid leukemia (AML) cells. Additionally, ZS3-046 demonstrates anti-tumor efficacy in AML xenograft mouse models.
    Formule :C49H57N9O7
    Couleur et forme :Solid
    Masse moléculaire :883.4381

    Ref: TM-T207298

    10mg
    À demander
    50mg
    À demander
  • Secalonic acid D

    CAS :
    Secalonic acid D, from Aspergillus aculeatus, is anti-tumor, activates GSK3-β, degrades β-catenin, inhibits c-Myc, and induces apoptosis.
    Formule :C32H30O14
    Couleur et forme :Solid
    Masse moléculaire :638.57

    Ref: TM-T75621

    5mg
    À demander
    50mg
    À demander
  • MS41

    CAS :
    MS41 is a selective eleven-nineteen leukemia (ENL) PROTAC degrader, with DC50s values of 3.50 nM (MV4;11), 2.84 nM (SEMK2), 3.03 nM (Jurkat), and 26.58 nM (KASUMI1). This compound effectively inhibits the growth of ENL-dependent leukemia cells, induces G1 cell cycle arrest, and increases cellular apoptosis (Apoptosis). Additionally, MS41 reduces chromatin occupancy related to ENL-mediated transcription elongation mechanisms and suppresses the expression of oncogenes and the progression of leukemia.
    Formule :C56H70N8O9S
    Couleur et forme :Solid
    Masse moléculaire :1031.27

    Ref: TM-T200591

    10mg
    À demander
    50mg
    À demander
  • GSK-3β inhibitor 15


    GSK-3β inhibitor 15 (Compound 54), with an IC50 of 3.4 nM, effectively suppresses Aβ 1-42-induced phosphorylation of GSK-3β and tau protein, as well as LPS-
    Formule :C17H16N6OS
    Couleur et forme :Solid
    Masse moléculaire :352.41

    Ref: TM-T78874

    5mg
    À demander
    50mg
    À demander
  • HDAC-IN-79


    HDAC-IN-79 (compound 4) is an orally active dual inhibitor of xanthine oxidase and HDAC, exhibiting potent anti-hyperuricemia and antitumor activities in vivo (Xanthine oxidase: IC50=6.6 nM; HDAC1: IC50=134 nM; HDAC2: IC50=284 nM; HDAC3: IC50=173 nM; HDAC6: IC50=1.32 nM). Among leukemia cells, it is most effective in inhibiting the growth of HL60 cells (IC50=0.706 μM) and induces both apoptosis and autophagy. HDAC-IN-79 also modulates the expression levels of biomarkers associated with intracellular HDAC inhibition.
    Couleur et forme :Odour Solid

    Ref: TM-T200527

    10mg
    À demander
    50mg
    À demander
  • ZMF-24


    ZMF-24 is an anti-triple-negative breast cancer (TNBC) agent that exhibits IC50 values of 0.22 μM and 0.44 μM against BT-549 and MDA-MB-231 TNBC cell proliferation, respectively. It targets the eukaryotic translation initiation factor 3 subunit D (EIF3D), disrupting TNBC's energy supply by inhibiting glycolysis. Additionally, ZMF-24 induces TNBC cell apoptosis (apoptosis) by stimulating sustained endoplasmic reticulum stress.
    Couleur et forme :Odour Solid

    Ref: TM-T200627

    10mg
    À demander
    50mg
    À demander
  • PK095

    CAS :

    PK095 is a proprietary compound in the guanidine - based F1F0-ATPase inhibitor family.

    Formule :C20H18N4O2S
    Degré de pureté :96.84%
    Couleur et forme :Soild
    Masse moléculaire :378.45

    Ref: TM-T67763

    1mg
    67,00€
    5mg
    143,00€
    10mg
    197,00€
    25mg
    314,00€
    50mg
    434,00€
    100mg
    587,00€
    200mg
    785,00€
  • Suramin

    CAS :
    Suramin is an RdRp and PTPase inhibitor with anti-parasitic, anti-tumor, and anti-angiogenic activities, inhibiting sirtuins and DNA topoisomerase II.
    Formule :C51H40N6O23S6
    Degré de pureté :99.80%
    Couleur et forme :Solid
    Masse moléculaire :1297.28

    Ref: TM-T75303

    1mg
    93,00€
    5mg
    197,00€
    10mg
    296,00€
  • PARP1/BRD4-IN-3


    PARP1/BRD4-IN-3 (compound HF4) is an effective inhibitor of BRD4 and PARP1, with IC50 values of 1210 nM and 2019 nM respectively. The compound exhibits antiproliferative activity, induces apoptosis (apoptosis) and cell cycle arrest at the G0/G1 phase. Additionally, PARP1/BRD4-IN-3 causes DNA damage and reduces the expression of the Rad51 protein, demonstrating anti-tumor activity.
    Couleur et forme :Odour Solid

    Ref: TM-T200653

    10mg
    À demander
    50mg
    À demander
  • Thalidomide-O-PEG4-amine

    CAS :
    Thalidomide-O-PEG4-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
    Formule :C23H31N3O9
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :493.51

    Ref: TM-T18827

    100mg
    À demander
    500mg
    À demander
  • 3-Hydroxykynurenine

    CAS :
    3-Hydroxykynurenine (3-hydroxy-DL-Kynurenine) is an active metabolite of tryptophan and inhibits yeast and rat liver aldehyde dehydrogenase by 97 and 69%.
    Formule :C10H12N2O4
    Degré de pureté :98.83% - 99.69%
    Couleur et forme :Solid
    Masse moléculaire :224.21

    Ref: TM-T37683

    2mg
    À demander
    5mg
    105,00€
    10mg
    154,00€
  • ElteN378

    CAS :
    ElteN378: potently inhibits FKBP12 (Ki=0.5 nM), low weight, similar affinity to Rapamycin.
    Formule :C23H26N2O3
    Degré de pureté :99.06%
    Couleur et forme :Solid
    Masse moléculaire :378.46

    Ref: TM-T9950

    1mg
    167,00€
    1mL*10mM (DMSO)
    295,00€
    5mg
    356,00€
    10mg
    528,00€
    25mg
    848,00€
    50mg
    1.153,00€
    100mg
    1.603,00€
    200mg
    2.142,00€
  • CDK8-IN-13

    CAS :
    CDK8-IN-13 is a CDK8 inhibitor (IC50: 51.9 nM) with potent, selective and oral activity.
    Formule :C14H11N3O
    Degré de pureté :99.28%
    Couleur et forme :Soild
    Masse moléculaire :237.26

    Ref: TM-T72029

    1mg
    35,00€
    5mg
    75,00€
    1mL*10mM (DMSO)
    75,00€
    10mg
    92,00€
    25mg
    167,00€
    50mg
    250,00€
    100mg
    371,00€
  • Ferroptosis-IN-12


    Ferroptosis-IN-12 (Cpd-A1) is an inhibitor of ferroptosis. It effectively suppresses ferroptosis in mouse renal tubular epithelial cells (mTECs) treated with Erastin and improves renal function in dose-dependent manners in mouse models of acute kidney injury (AKI) induced by ischemia/reperfusion (I/R) or cecal ligation and puncture (CLP). This compound also reduces renal tubular damage and eliminates inflammation. Exhibiting good plasma stability and high distribution in renal tissues during pharmacokinetic studies in mice, Ferroptosis-IN-12 shows promising potential for research in the field of AKI.
    Couleur et forme :Odour Solid

    Ref: TM-T200665

    10mg
    À demander
    50mg
    À demander
  • STAT3-D11-PROTAC-VHL


    STAT3-D11-PROTAC-VHL (Compound D11-PROTAC) is a PROTAC degrader targeting signal transducer and activator of transcription 3 (STAT3). It demonstrates anti-tumor activity with IC50 values of 1335 nM in HeLa cells and 1973 nM in MCF-7 cells. The compound binds to the DNA binding domain of STAT3, recruits the E3 ligase VHL to form a ternary complex, leading to ubiquitination and subsequent proteasomal degradation of STAT3. Additionally, STAT3-D11-PROTAC-VHL inhibits tumor cell growth, induces cell cycle arrest and apoptosis (apoptosis), and suppresses tumor immune evasion.
    Couleur et forme :Odour Solid

    Ref: TM-T207293

    10mg
    À demander
    50mg
    À demander
  • RIPK1-IN-17

    CAS :
    RIPK1-IN-17 is a dual inhibitor of RIPK1 and RIPK3 inhibits necrosis by inhibiting phosphorylation of RIPK1, RIPK3 and MLKL,in a tnf-induced inflammation model.
    Formule :C26H19F4N3O3S
    Degré de pureté :95.22%
    Couleur et forme :Solid
    Masse moléculaire :529.51

    Ref: TM-T81268

    1mg
    50,00€
    5mg
    99,00€
    10mg
    152,00€
    25mg
    250,00€
    50mg
    369,00€
  • Tubulin/AKT1-IN-1


    Tubulin/AKT1-IN-1 (Compound D1-1) serves as an inhibitor of both tubulin polymerization and AKT pathway activation, effectively suppressing proliferation and
    Formule :C38H34ClNO11
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :716.13

    Ref: TM-T79214

    5mg
    À demander
    50mg
    À demander